---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-22-000631"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:19:43.620486+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# iRadimed Q3 revenue up 23% to $13.4M; GAAP EPS $0.27; guides Q4 rev $14.1-14.8M

## Summary
- Q3 revenue $13.4M (+23% YoY), operating income $4.1M (+32%), GAAP EPS $0.27 (+35%).
- Non-GAAP net income $3.7M (excl. $0.3M stock comp); nine-month non-GAAP EPS $0.78 vs $0.50.
- Gross margin improved to 78.6% from 77.1%; operating cash flow $3.9M in Q3.
- Q4 guidance: revenue $14.1-14.8M, GAAP EPS $0.23-0.28, non-GAAP EPS $0.25-0.30.
- CEO cites strong bookings and backlog; purchased 27 acres in Orlando for future HQ, tripling space.

## SEC filing metadata
- accession: 0000898432-22-000631
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000631/0000898432-22-000631-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000631/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-22-000631
- JSON: https://secwatch.observer/filing/0000898432-22-000631.json
- Plain text: https://secwatch.observer/filing/0000898432-22-000631.txt

## Key facts
- Earnings Releases
  IRADIMED CORP reported financial results for the third quarter ended September 30, 2022.
  - Period: the third quarter ended September 30, 2022
  - Result: reported results
  source text: On November 3, 2022, iRadimed Corporation issued a press release (the “Press Release”) announcing its financial results for the third quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000089843222000631/0000898432-22-000631-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.